» Articles » PMID: 8144855

Glycosylation of Human Prolactin Regulates Hormone Bioactivity and Metabolic Clearance

Overview
Publisher Springer
Specialty Endocrinology
Date 1993 Nov 1
PMID 8144855
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

To analyze the role of individual glycosylation pattern on PRL biopotency, monomeric prolactin (PRL), secreted by human prolactinoma cells in culture, was isolated by gel filtration and separated by affinity chromatography on Concanavalin A-Sepharose or Lentil-Agarose. These lectins allowed the isolation of PRL glycoforms containing either biantennary, mannose-rich or fucosylated complex carbohydrate structures, respectively. Endoglycosidase treatment and carbohydrate content of PRL was found to be consistent with N-linked oligosaccharides of mannose-rich structure and complex units terminated in sialic acid. Mannose-rich PRL and PRL with biantennary oligosaccharides promoted cell growth of rat lymphoma cells to a diminished extent compared to non-glycosylated PRL (NG-PRL), indicating that the two major types of carbohydrate structure are able to decrease the intrinsic bioactivity of PRL. Metabolic clearance of the various forms of PRL in rats was also found to be highly dependent upon hormone glycosylation. The various glycosylated forms (G-PRLs) proved to be totally eliminated from the circulation within 60 min, faster than NG-PRL 10% of which was still present at that time. Mannose-rich or biantennary G-PRLs were differently cleared in a biphasial fashion with a similar rapid phase of about 2 min followed by distinct slow phases of 12 and 27 min, respectively. The presence of fucose did not alter this distribution. In contrast, NG-PRL was eliminated with a half-time of approximately 5 min, followed by a very slow disappearance over several h. It thus appeared that glycosylation increased the metabolic clearance rate of PRL from 0.13 +/- 0.07 ml/min for NG-PRL to 0.47 +/- 0.12 ml/min for PRL with biantennary carbohydrate chains and 0.8 +/- 0.2 ml/min for the hormone with mannose-rich oligosaccharides. The distribution of PRL to target and elimination organs was also found to be different according to the carbohydrate structure present in the hormone. NG-PRL and mannose-rich G-PRL showed higher incorporation in liver than biantennary G-PRL which was preferentially eliminated by the kidney. Altogether, the current data show that addition of oligosaccharides to PRL as well as carbohydrate structure contribute to modulate both the duration of the hormone in the blood and its distribution to different organs. It is proposed that glycosylation may selectively down-regulate PRL action at individual target tissues.

Citing Articles

Human Pituitary Adenoma Proteomics: New Progresses and Perspectives.

Zhan X, Wang X, Cheng T Front Endocrinol (Lausanne). 2016; 7:54.

PMID: 27303365 PMC: 4885873. DOI: 10.3389/fendo.2016.00054.


Placental endoplasmic reticulum stress negatively regulates transcription of placental growth factor via ATF4 and ATF6β: implications for the pathophysiology of human pregnancy complications.

Mizuuchi M, Cindrova-Davies T, Olovsson M, Charnock-Jones D, Burton G, Yung H J Pathol. 2015; 238(4):550-61.

PMID: 26648175 PMC: 4784173. DOI: 10.1002/path.4678.


Immunoassay and Nb2 lymphoma bioassay prolactin levels and mammographic density in premenopausal and postmenopausal women the Nurses' Health Studies.

Rice M, Tworoger S, Bertrand K, Hankinson S, Rosner B, Feeney Y Breast Cancer Res Treat. 2014; 149(1):245-53.

PMID: 25503962 PMC: 4381437. DOI: 10.1007/s10549-014-3232-z.


Bioactive prolactin levels and risk of breast cancer: a nested case-control study.

Tworoger S, Rice M, Rosner B, Feeney Y, Clevenger C, Hankinson S Cancer Epidemiol Biomarkers Prev. 2014; 24(1):73-80.

PMID: 25315962 PMC: 4294963. DOI: 10.1158/1055-9965.EPI-14-0896.


A 20-year prospective study of plasma prolactin as a risk marker of breast cancer development.

Tworoger S, Eliassen A, Zhang X, Qian J, Sluss P, Rosner B Cancer Res. 2013; 73(15):4810-9.

PMID: 23783576 PMC: 3738582. DOI: 10.1158/0008-5472.CAN-13-0665.


References
1.
Hiyama J, Weisshaar G, Renwick A . The asparagine-linked oligosaccharides at individual glycosylation sites in human thyrotrophin. Glycobiology. 1992; 2(5):401-9. DOI: 10.1093/glycob/2.5.401. View

2.
Pellegrini I, Gunz G, Ronin C, Fenouillet E, Peyrat J, Delori P . Polymorphism of prolactin secreted by human prolactinoma cells: immunological, receptor binding, and biological properties of the glycosylated and nonglycosylated forms. Endocrinology. 1988; 122(6):2667-74. DOI: 10.1210/endo-122-6-2667. View

3.
Sinha Y, DePaolo L, Haro L, Singh R, Jacobsen B, Scott K . Isolation and biochemical properties of four forms of glycosylated porcine prolactin. Mol Cell Endocrinol. 1991; 80(1-3):203-13. DOI: 10.1016/0303-7207(91)90157-n. View

4.
Bollengier F, Hooghe R, Velkeniers B, Mahler A, Vanhaelst L, Hooghe-Peters E . Further characterization of rat 26,000 prolactin as a glycoprotein with essentially o-linked carbohydrate chains. J Neuroendocrinol. 2009; 3(4):375-81. DOI: 10.1111/j.1365-2826.1991.tb00290.x. View

5.
Smith P, Baenziger J . Molecular basis of recognition by the glycoprotein hormone-specific N-acetylgalactosamine-transferase. Proc Natl Acad Sci U S A. 1992; 89(1):329-33. PMC: 48230. DOI: 10.1073/pnas.89.1.329. View